From January 1, 2024 to March 1, 2024, the company has repurchased 5,105,100 shares, representing 1.08% for ¥12,755.57 million. With this, the company has completed the repurchase of 18,732,400 shares, representing 3.88% for ¥49,999.75 million under the buyback announced on July 25, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,320 JPY | +1.16% | +0.63% | -7.79% |
Apr. 30 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
Apr. 29 | US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.79% | 6.91B | |
+21.09% | 43.27B | |
+25.28% | 22.92B | |
+19.22% | 15.43B | |
+13.51% | 12.95B | |
+44.01% | 11.83B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.02% | 5.55B | |
+9.14% | 4.9B |
- Stock Market
- Equities
- 4528 Stock
- News Ono Pharmaceutical Co., Ltd.
- Tranche Update on Ono Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023.